In vivo experiments showed that the volume of the tumor increased over time, but METTL14 knockdown significantly reduced the volume of the tumor at week 5 (P < 0.05, Fig. 5), which implied that METTL14 knockdown could inhibit tumor formation and growth. Here, METTL14 is linked to neoplasm.